Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-23 Sale |
2021-03-25 4:13 pm |
Gossamer Bio Inc. | GOSS | Salter-Cid Luisa Chief Scientific Officer |
5,491 | $9.4795 | $52,052 | 206,065 (Direct) |
View |
| 2021-03-23 Sale |
2021-03-25 4:11 pm |
Gossamer Bio Inc. | GOSS | Giraudo Bryan Chief Financial Officer |
5,490 | $9.4801 | $52,046 | 117,010 (Indirect Direct) |
View |
| 2021-03-23 Sale |
2021-03-25 4:09 pm |
Gossamer Bio Inc. | GOSS | Christian Waage EVP & General Counsel |
5,490 | $9.481 | $52,051 | 617,375 (Indirect Direct) |
View |
| 2020-10-14 Purchase |
2020-10-14 7:29 pm |
Gossamer Bio Inc. | GOSS | Christian Waage EVP & General Counsel |
2,500 | $9.5272 | $23,818 | 577,174 (Indirect Direct) |
View |
| 2020-10-14 Purchase |
2020-10-14 7:28 pm |
Gossamer Bio Inc. | GOSS | Hasnain Faheem Director |
96,520 | $10.36 | $999,995 | 3,478,629 (Indirect) |
View |
| 2020-10-14 Purchase |
2020-10-14 7:27 pm |
Gossamer Bio Inc. | GOSS | Giraudo Bryan Chief Financial Officer |
3,000 | $10.01 | $30,036 | 77,500 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-16 Option Award |
2021-04-20 6:07 pm |
N/A 2031-04-16 |
Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs |
42,570 | $0 | 106,578 (Direct) |
View |
Ownership |
2021-04-20 5:43 pm |
N/A N/A |
Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs |
0 | $0 | 324,015 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 7:40 pm |
N/A 2031-02-25 |
Gossamer Bio Inc. | GOSS | Hasnain Faheem President & CEO |
487,500 | $0 | 3,966,129 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 4:54 pm |
N/A 2031-02-25 |
Gossamer Bio Inc. | GOSS | Salter-Cid Luisa Chief Scientific Officer |
135,000 | $0 | 301,556 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 4:50 pm |
N/A 2031-02-25 |
Gossamer Bio Inc. | GOSS | Giraudo Bryan Chief Financial Officer |
135,000 | $0 | 212,500 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 4:37 pm |
N/A 2031-02-25 |
Gossamer Bio Inc. | GOSS | Christian Waage EVP & General Counsel |
135,000 | $0 | 712,865 (Direct) |
View |